Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · fourth_quarter · 4A
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385
Source: Senate LDA
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Domestic Manufacturing Credit Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform International Tax Issues Treasury Anti-inversion Regulation Section 385
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Domestic Manufacturing Credit Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform International Tax Issues Treasury Anti-inversion Regulation Section 385
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Domestic Manufacturing Credit Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R. 1, Tax Reform Act of 2014 Innovation Promotion Act of 2015 (Patent/Innovation Box draft legislation) Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income Transfer Pricing
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014 Obama Administration 2016 Budget Proposals Senate Finance Committee Tax Reform Process
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
Protect Medical Innovation Act of 2015
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
CMS Coverage Policies CMS Payment Policies H.R. 6, 21st Century Cures Act Senate Innovation Initiative
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate Innovation Initiative
CMS Coverage Policies For Medical Devices CMS Payment Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
CMS Coverage Policies For Medical Devices CMS Payment Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014 Obama Administration 2016 Budget Proposals Senate Finance Committee Tax Reform Process
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014 Obama Administration 2016 Budget Proposals Senate Finance Committee Tax Reform Process
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Medical Device Postmarket Surveillance H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013 Enhanced Surgical Recovery Protocols 21st Century Cures and other Device Innovation Initiatives
Implementation of PL-111-148, Patient Protection and Affordable Care Act; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance; H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013"; Enhanced Surgical Recovery Protocols; 21st Century Cures and other Device Innovation Initiatives;
Implementation of PL-111-148, Patient Protection and Affordable Care Act; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance; H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013"; Enhanced Surgical Recovery Protocols; 21st Century Cures and other Device Innovation Initiatives;
Protect Medical Innovation Act of 2013
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovation Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Protect Medical Innovation Act of 2013
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Protect Medical Innovation Act of 2013
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R. 523, Protect Medical Innovation Act of 2013 S. 232 Medical Device Access & Innovation Protection Act
Protect Medical Innovation Act of 2013
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovation Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R. 523, Protect Medical Innovation Act of 2013 S. 232 Medical Device Access & Innovation Protection Act
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovation Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovation Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Protect Medical Innovation Act of 2013
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Protect Medical Innovation Act of 2013
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Protect Medical Innovation Act of 2013
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Protect Medical Innovation Act of 2013
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Medical Device Access and Innovation Protection Act
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Novel Device Regulatory Relief Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Guidance Accountability and Transparency Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Patients Come First Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Premarket Predictability Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Humanitarian Device Reform Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Food and Drug Administration Mission Reform Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Keeping America Competitive Through Harmonization Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
Health Care Cost Reduction Act of 2012
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; HR. 436 Health Care Cost Reduction Act of 2012; S.17 Medical Device Access & Innovation Protection Act.
Health Care Cost Reduction Act of 2012
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; HR. 436 Health Care Cost Reduction Act of 2012; S.17 Medical Device Access & Innovation Protection Act; H.R.8 American Taxpayer Relief Act of 2012
Food and Drug Administration Reform Act of 2012
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; H.R. 5651, "Food and Drug Administration Reform Act of 2012"; S. 3187, "Food and Drug Administration Safety and Innovation Act";
Food and Drug Administration Reform Act of 2012
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; H.R. 5651, "Food and Drug Administration Reform Act of 2012"; S. 3187, "Food and Drug Administration Safety and Innovation Act";
American Taxpayer Relief Act of 2012
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; HR. 436 Health Care Cost Reduction Act of 2012; S.17 Medical Device Access & Innovation Protection Act; H.R.8 American Taxpayer Relief Act of 2012
Novel Device Regulatory Relief Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Guidance Accountability and Transparency Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Patients Come First Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Premarket Predictability Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Humanitarian Device Reform Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Food and Drug Administration Mission Reform Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Keeping America Competitive Through Harmonization Act of 2011
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Patent Reform Act of 2009
Client: EDWARDS LIFESCIENCES LLC · Firm: EDWARDS LIFESCIENCES, LLC
Patent Reform-S. 515, H.R. 1260
S. 506/ H.R. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income excise tax of medical devices
S. 506/ HR. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income excise tax for medical devices
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · fourth_quarter · Q4
Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues Treasury Anti-inversion Regulation Section 385
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveilance FDA Inspection Process
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S.2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · third_quarter · Q3
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform International Tax Issues Treasury Anti-inversion Regulation Section 385
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · second_quarter · Q2
Domestic Manufacturing Credit Federal Corporate Tax Rate H.R 160, Protect Medical Innovation Act of 2015 Repatriation S. 149, Medical Device Access & Innovation Protection Act Tax Reform Taxation of Offshore Income International Tax Issues
CMS Coverage Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices Coverage and reimbursement policy for medical devices/THV HR 5009, Ensuring Patient Access to Critical Breakthrough Products Act of 2016 S. 2998, Ensuring Patient Access to Critical Breakthrough Products Act of 2016
H.R. 160, Protect Medical Innovation Act of 2015 H.R. 6, 21st Century Cures Act S. 149, Medical Device Access & Innovation Protection Act Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2016 · first_quarter · Q1
CMS Coverage Policies For Medical Devices Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices
Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems
Domestic Manufacturing Credit Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R. 1, Tax Reform Act of 2014 Innovation Promotion Act of 2015 (Patent/Innovation Box draft legislation) Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income Transfer Pricing
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2015 · fourth_quarter · Q4
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
CMS Coverage Policies For Medical Devices CMS Payment Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2015 · third_quarter · Q3
CMS Coverage Policies For Medical Devices CMS Payment Policies For Medical Devices H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative
Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act Innovation Promotion Act of 2015 (Boustany Innovation/Patent Box Leg) H.R. 1, Tax Reform Act of 2014 Obama Administration 2016 Budget Proposals Senate Finance Committee Tax Reform Process
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2015 · second_quarter · Q2
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate Innovation Initiative
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2015 · first_quarter · Q1
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R 160, Protect Medical Innovation Act of 2015 S. 149 Medical Device Access & Innovation Protection Act Patent Box
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols 21st Century Cures and other Device Innovation Initiatives
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2014 · fourth_quarter · Q4
Implementation of PL-111-148, Medical Device Tax Foreign Source Income Tax Deferral Taxation of Offshore Income Tax Reform Federal Corporate Tax Rate Repatriation Transfer Pricing R&D Tax Credit Domestic Manufacturing Credit H.R. 523, Protect Medical Innovation Act of 2013 S. 232 Medical Device Access & Innovation Protection Act
Implementation of PL-111-148, Patient Protection and Affordable Care Act Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Medical Device Postmarket Surveillance H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013 Enhanced Surgical Recovery Protocols 21st Century Cures and other Device Innovation Initiatives
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2014 · third_quarter · Q3
CMS Coverage Policies; CMS Payment Policies; Inpatient Prospective Payment System Proposed Rule;
Implementation of PL-111-148, Patient Protection and Affordable Care Act; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance; H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013"; Enhanced Surgical Recovery Protocols; 21st Century Cures and other Device Innovation Initiatives;
Veteran Access to Transcatheter Heart Valve Therapies;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2014 · second_quarter · Q2
Implementation of PL-111-148, Patient Protection and Affordable Care Act; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance; H.R. 3303, "SOFTWARE Act of 2013: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013"; Enhanced Surgical Recovery Protocols; 21st Century Cures and other Device Innovation Initiatives;
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovation Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2014 · first_quarter · Q1
Implementation of PL-111-148, Patient Protection and Affordable Care Act; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance;
CMS Coverage Policies; Medicare Payment Bundling Initiatives; CMS Payment Policies
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2013 · fourth_quarter · Q4
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
CMS Coverage Policies; Accountable Care Organizations; Medicare Payment Bundling Initiatives; CMS Payment Policies
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2013 · third_quarter · Q3
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance;
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
CMS Coverage Policies; Accountable Care Organizations; Medicare Payment Bundling Initiatives;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2013 · second_quarter · Q2
US-Russian Trade Policy; EU Medical Device Regulation
Implementation of PL-111-148: Physician Payment Disclosure; CMS Coverage Policies; Accountable Care Organizations; Medicare Payment Bundling Initiatives;
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act"; Medical Device Postmarket Surveillance;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2013 · first_quarter · Q1
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act";
Implementation of PL-111-148: Physician Payment Disclosure; CMS Coverage Policies
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2012 · fourth_quarter · Q4
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; HR. 436 Health Care Cost Reduction Act of 2012; S.17 Medical Device Access & Innovation Protection Act; H.R.8 American Taxpayer Relief Act of 2012
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; Implementation of PL-112-144, "Food and Drug Administration Safety and Innovation Act";
Implementation of PL-111-148: Physician Payment Disclosure; CMS Coverage Policies
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2012 · third_quarter · Q3
Implementation of PL-111-148: Physician Payment Disclosure; CMS Coverage Policies
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; H.R. 5651, "Food and Drug Administration Reform Act of 2012"; S. 3187, "Food and Drug Administration Safety and Innovation Act";
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; HR. 436 Health Care Cost Reduction Act of 2012; S.17 Medical Device Access & Innovation Protection Act.
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2012 · second_quarter · Q2
Implementation of PL-111-148: Physician Payment Disclosure; CMS Coverage Policies
Implementation of PL-111-148; Issues related to improving outcome in sepsis treatment; H.R. 5651, "Food and Drug Administration Reform Act of 2012"; S. 3187, "Food and Drug Administration Safety and Innovation Act";
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2012 · first_quarter · Q1
Implementation of PL-111-148: Comparative Effectiveness; Physician Payment Disclosure; CMS Coverage with Evidence Development Policies
510(k) Reform; Medical device user fee implementation; H.R. 3209, the "Premarket Predictability Act"; H.R. 3203, the "Novel Device Regulatory Relief Act of 2011"; H.R. 3230, "Keeping America Competitive through Harmonization Act"; H.R. 3211, "Humanitarian Device Reform Act of 2011"; H.R. 3208, "Patients Comfe First Act"; H.R. 3206, "Cultivating Scientific Expertise to Foster Innovation Act" ; H.R. 3214, "Food and Drug Administration Mission Reform Act"; H.R. 3207 "Modernizing Laboratory Test Standards for Patients Act"; H.R. 3204, "Guidance Accountability and Transparency Act"; H.R. 3205, "FDA Renewing Efficiency from Outside Review Management Act of 2011"; S. 1700 "The Medical Device Regulatory Act"; S.1865 "The Patient Access to Medical Innovation Act"; S. 1943 "Novel Device Regulatory Relief Act"; S. 1972, "A Bill to Amend the Food and Drug Administration's Mission"; S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes; S. 2067Safe, Transparent, and Efficient Medical Device Act or SET Device Act; S. 2113A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health."; S. 219, Ensuring Safe Medical Devices for Patients
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2011 · fourth_quarter · Q4
510(k) Reform; Medical device user fee implementation; H.R. 3209, the Premarket Predictability Act; H.R. 3203, the Novel Device Regulatory Relief Act of 2011; H.R. 3230, Keeping America Competitive through Harmonization Act ; H.R. 3211, Humanitarian Device Reform Act of 2011; H.R. 3208, Patients Come First Act; H.R. 3206, Cultivating Scientific Expertise to Foster Innovation Act ; H.R. 3214, Food and Drug Administration Mission Reform Act; H.R. 3207, Modernizing Laboratory Test Standards for Patients Act; H.R. 3204, Guidance Accountability and Transparency Act; H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act of 2011
Implemenation of PL-111-148; Medical device user fee implementation
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2011 · third_quarter · Q3
Implementation of PL-111-148
Implementation of PL-111-148: Comparative Effectiveness; Physician Payment Disclosure; CMS Coverage Policies
510(k) Reform
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2011 · second_quarter · Q2
Patent Reform
Implementation of PL-111-148; Foreign Source Income Tax Deferral; Taxation of Offshore incomes; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer pricing; R&D Tax Credit; Domestic Manufacturing Credit
Implementation of PL-111-148: Comparative Effectiveness; Physician Payment Disclosure; Accountable Care Organizations
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2011 · first_quarter · Q1
510(k) Reform FDA Medical Device Innovation Intiative
H.R. 658, H ADMT 210: Regulation of transportation of lithium batteries
Implementation of PL-111-148; Foreign Source Income Tax Deferral; Taxation of Offshore incomes; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer pricing; R&D Tax Credit; Domestic Manufacturing Credit
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2010 · fourth_quarter · Q4
Implementation of PL-111-148
S. 506/ H.R. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income excise tax of medical devices
Implementation of PL-111-148
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2010 · third_quarter · Q3
S. 506/H.R. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income excise tax of medical devices
HR 579 Food and Drug Administration Globalization Act 2009 510(k) Reform
Implementation of PL-111-148
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2010 · second_quarter · Q2
H.R. 579 Food and Drug Administration Globalization Act 2009 510(k) Reform
S.540/ HR 1346 Medical Device Safety Act of 2009
Gift Disclosure Comparative Effectiveness Research Healthcare Reform-HR 3200 America's Health Choices Act of 2009; S. 1679 Affordable Health Choices Act of 2009; America's Healthy Future Act of 2009; H.R. 3590 Patient Protection and Affordable Care Act
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2010 · first_quarter · Q1
Comparative Effectiveness; Gift Disclosure; Health Care Reform-HR 3200 America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; America's Healthy Future Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act; H.R. 4872 Health Care and Education Reconciliation Act of 2010 Medical Device Tax
S. 506/ HR. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income excise tax for medical devices
S.540/ HR 1346 Medical Device Safety Act of 2009
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2009 · fourth_quarter · Q4
Chinese ban on certain medical devices
HR 759 Food and Drug Administration Globalization Act 2009 510(k) Reform
S. 540/ H.R. 1346, Medical Device Safety Act of 2009
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2009 · third_quarter · Q3
HR 759, Food and Drug Administration Globalization Act 2009 510(k) Reform
S. 540/ HR 1346, Medical Device Safety Act of 2009
trade barriers
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2009 · second_quarter · Q2
S. 540/ HR 1346, Medical Device Safety Act of 2009
Gift Disclosure-S.301 Comparative Effectiveness Research
S. 506/ H.R. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2009 · first_quarter · 1A
Patent Reform S.515, H.R. 1260
HR 759, Food and Drug Administration Globalization Act 2009
Comparative Effectiveness- H.R. 1, S. 336
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2009 · first_quarter · Q1
Preemption H.R.6831, S.3398
Gift Disclosure- S.2029
Comparative Effectiveness- H.R. 1, S. 336
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · fourth_quarter · 4A
HR 1321, Medicare Advanced Laboratory Diagnostics Act of 2007 S. 631, Remote Monitoring Access Act of 2007 S. 2221, Transparency in Medical Device pricing Act of 2007 H.R. 6381, Medical Device Safety Act S. 2029 Gift Disclosure
FY 2009 appropriations for the FDA
Comparative Effectiveness
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · third_quarter · 3A
Comparative Effectiveness
Patent Reform H.R. 1908, S. 1145
HR 1321, Medicare Advanced Laboratory Diagnostics Act of 2007 S. 631, Remote Monitoring Access Act of 2007 S. 2221, Transparency in Medical Device pricing Act of 2007; price transparency H.R. 6381, Medical Device Safety Act, S. 3398 S. 2029 gift disclosure
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · second_quarter · 2A
FY 2009 appropriations for the FDA
Comparative Effectiveness
Patent Reform; HR 1908, S. 1145
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · first_quarter · 1A
Preemption
Agriculture Appropriations
Patent Reform; HR 1908, S. 1145
Comparative Effectiveness
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · fourth_quarter · Q4
Preemption HR. 6831, S. 3398
Comparative Effectiveness
Price Transparency; Gift Disclosure-S. 2029
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · third_quarter · Q3
Comparative Effectiveness
price transparency; gift disclosure S. 2029
Patent Reform; HR 1908; S 1145
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · first_quarter · 1A
Imaging Reimbursement rate; price transparecny; gift disclosure
Comparative Effectiveness
FY09 FDA Appropriations
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · second_quarter · Q2
imaging reimbursement rates; price transparency; gift disclosure
FY-09 FDA Appropriations
Patent Reform; H.R. 1908; S. 1145
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2008 · first_quarter · Q1
Imaging reimbursement rates; price transparency; gift disclosure
Preemption
Patent Reform; H.R. 1908; S.1145
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2007 · year_end · YY
Farm Bill
Imaging reimbursement rates; price transparency; gift disclosure
MDUFMA, FY09 FDA Appropriations
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2007 · year_end · RA
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
EDWARDS LIFESCIENCES LLC via EDWARDS LIFESCIENCES, LLC
2007 · year_end · RA
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Implementation of PL-112-144, Food and Drug Administration Safety and Innovation Act Enhanced Surgical Recovery Protocols H.R. 6, 21st Century Cures Act Senate "Innovation for Healthier Americans" Initiative H.R. 160, Protect Medical Innovation Act of 2015 S. 149, Medical Device Access & Innovation Protection Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies CMS Payment Policies H.R. 6, 21st Century Cures Act Senate Innovation Initiative
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies CMS Payment Policies 21st Century Cures and other Device Innovation Initiatives
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies CMS Payment Policies 21st Century Cures and other Device Innovation Initiatives
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovation Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CMS Coverage Policies; CMS Payment Policies; Inpatient Prospective Payment System Proposed Rule; Post Acute Transfer Policy;
Veteran Access to Transcatheter Heart Valve Therapies;
Japan Foreign Average Pricing Policy;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit, Domestic Manufacturing Credit; H.R. 523 Protect Medical Innovaton Act of 2013; S.232 Medical Device Access & Innovation Protection Act;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit; Domestic Manufacturing Credit
Implementation of PL-111-148; Medical device user fee implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Implementation of PL-111-148 (Medical Device Tax); Foreign Source Income Tax Deferral; Taxation of Offshore Income; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit; Domestic Manufacturing Credit
Implementation of PL-111-148: Comparative Effectiveness; Physician Payment Disclosure; CMS Coverage Policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office
Implementation of PL-111-148; Foreign Source Income Tax Deferral; Taxation of Offshore incomes; Tax Reform; Federal Corporate Tax Rate; Repatriation; Transfer Pricing; R&D Tax Credit; Domestic Manufacturing Credit
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
510(k) Reform
Implementation of PL-111-148
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Implementation of PL-111-148: Comparative Effectiveness; Physician Payment Disclosure; Accountable Care Organizations
Implementation of PL-111-148
Patent Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), Treasury, Dept of
HR 579 Food and Drug Administration Globalization Act 510(k) Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
implementation of PL-111-148
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Comparative Effectiveness; Gift Disclosure; Health Care Reform-HR3200 America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; America's Healthy Future Act of 2009; H.R. 3590 Patient Protection and Affordable Care Act; H.R. 4872 Health Care and Education Reconciliation Act of 2010 Medical Device Tax
S. 506/ H.R. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income excise tax of medical devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R. 759 Food and Drug Administration Globalization Act 2009 510(k) Reform
Chinese ban on certain medical devices
Gift Disclosure Comparative Effectiveness Research Healthcare Reform- HR 3200 America's Health Choices Act of 2009; S. 1679 Affordable Health Choices Act of 2009; America's Healthy Future Act of 2009; H.R. 3590 Patient Protection and Affordable Care Act
Patent Reform-S. 515, H.R. 1260
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Gift Disclosure S. 301 Comparative Effectiveness Research Healthcare Reform- H.R. 3200 America's Health Choices Act of 2009; S. 1679 Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009
Patent Reform S. 515, H.R. 1260
Comparative Effectiveness Research; Gift Disclosure Healthcare Reform- H.R. 3200 America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Medical Device Tax
S. 506/ H.R. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income excise tax for medical devices
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Comparative Effectiveness Research; Gift Disclosure Healthcare reform- H.R. 3200 America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Medical Device Tax
Patent Reform S.515, H.R. 1260
Gift Disclosure-S.301 Comparative Effectiveness Research Healthcare reform- H.R. 3200 America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009
S. 506/ H.R. 1265 Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income Excise Tax for Medical Devices
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Comparative Effectiveness-H.R. 1; S. 336
HR 759, Food and Drug Administration Globalization Act 2009
trade barriers
Patent Reform S.515, H.R. 1260
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
S. 540/ HR 1346, Medical Device Safety Act of 2009
S. 506/ HR 1265, Stop Tax Haven Abuse Act tax deferral issue taxation of offshore income
Gift Disclosure- S.301
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent Reform S.515, H.R. 1260
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FY 2009 appropriations for the FDA
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 1321, Medicare Advanced Laboratory Diagnostics Act of 2007 S. 631, Remote Monitoring Access Act of 2007 S. 2221, Transparency in Medical Device pricing Act of 2007 H.R. 6381 Medical Device Safety Act, Preemption gift disclosure
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
China, FDA MOA
HR 1321, Medicare Advanced Laboratory Diagnostics Act of 2007 S. 631, Remote Monitoring Access Act of 2007 S. 2221, Transparency in Medical Device pricing Act of 2007 Gift Disclosure
FY 2009 appropriations for the FDA
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Preemption HR. 6381; S. 3398
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Agriculture Appropriations
Preemption
Patent Reform; H.R. 1908; S. 1145
China; FDA MOA
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Preemption
Comparative Effectiveness
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FY09 FDA Appropriations
Comparative Effectiveness
China; FDA MOA
Agriculture Appropriations
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
China/FDA MOA
MDUFMA
Patent Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform
Medicare Hospital Inpatient Prospective Payment System Rule, Comparative Effectiveness, FDA Medical Device User Fees, FDA Appropriations, Clinical Trial Registries, Preemption, FDA Conflicts of Interests, Physician Gift Disclosure, Pricing Transparency, Non-tariff trade barriers for medical devices, Tax Reform, Agriculture, Patent Reform